Google
RVTY 株価分析 — REVVITY INC. (Healthcare >> Diagnostics & Research)
RVTY に関するよくある質問
RVTYのPER（株価収益率）は？
REVVITY INC.（RVTY）は現在PER 52.57倍で取引されています。
RVTYのROE（自己資本利益率）は？
REVVITY INC.のROEは3.35%です。
RVTYの配当利回りは？
REVVITY INC.の配当利回りは0.25%です。
RVTYの品質スコア（Quality Score）は？
当社のAIはRVTYの総合財務品質を100点中46点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
RVTYは今が買い時ですか？
当社AIのタイミングスコアは100点中89点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
RVTYはどのセクターに属しますか？
REVVITY INC.はHealthcare >> Diagnostics & Researchセクターに分類されます（NYSE市場）
RVTY AI Analysis Summary
Our AI summary for RVTY: REVVITY INC. (NYSE), Healthcare >> Diagnostics & Research sector. The stock currently trades at a P/E of 52.57, ROE of 3.35%, a dividend yield of 0.25%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 112.52
Price
-1.02
(-0.90%)
Day Change
|
|
|---|
RVTY, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROEが低い
ROEの伸びが低い
平均ROEが低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
44% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
2804
|
| Magic Formula Rank by ROE |
2804
|
| Magic Formula Rank by ROIC |
2897
|
| Price | 112.52 |
| PBV / Sector |
1.76 / -29.69
|
| Earning Per Share | 2.14 |
| PE / Sector |
52.57 / 48.18
|
| PEG or PE/Growth / Sector |
-0.32 / 1.64
|
| Average 1M Daily Value |
127.41 M
GREAT
|
| Average 1W Daily Value |
167.21 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
52% |
| ポイントになる統計 |
|
54% |
| 配当 |
|
41% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:26 |
| Symbol | RVTY |
| Name | REVVITY INC. |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NYSE |
| Listed Shares | 111.56 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 12,666.50 / 38,081.42 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 77 4th Avenue, Waltham, MA, United States, 02451
Phone: 781 663 6900
Website: https://www.revvity.com
Employees: 11,000
Description: Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
